Literature DB >> 17497842

Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1.

Edwin S Tan1, Motonori Miyakawa, James R Bunzow, David K Grandy, Thomas S Scanlan.   

Abstract

3-iodothyronamine (1, T1AM) is a naturally occurring derivative of thyroid hormone that can potently activate the orphan G protein-coupled receptor (GPCR) known as the trace amine-associated receptor 1 (TAAR1). We have previously found that modifying the outer ring of the phenoxyphenethylamine core scaffold of 1 can improve potency and provide potent agonists. In this study, we explored the tolerance of rat and mouse TAAR1 (rTAAR1 and mTAAR1) for structural modifications in the ethylamine portion of 1. We found that incorporating unsaturated hydrocarbon substituents and polar, hydrogen-bond-accepting groups were beneficial for rTAAR1 and mTAAR1, respectively, providing compounds that were equipotent or more potent than 1. Additionally, we have discovered that a naphthyl group is an excellent isosteric replacement for the iodophenyl ring of 1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497842     DOI: 10.1021/jm0700417

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.

Authors:  Rajan Giri; Hari K Namballa; Ananta Sarker; Ian Alberts; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2020-06-04       Impact factor: 2.823

2.  Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class.

Authors:  Anita H Lewin; Gregory M Miller; Brian Gilmour
Journal:  Bioorg Med Chem       Date:  2011-10-13       Impact factor: 3.641

3.  Cu-catalyzed arylation of phenols: synthesis of sterically hindered and heteroaryl diaryl ethers.

Authors:  Debabrata Maiti; Stephen L Buchwald
Journal:  J Org Chem       Date:  2010-03-05       Impact factor: 4.354

Review 4.  Trace amine-associated receptors as emerging therapeutic targets.

Authors:  Tatyana D Sotnikova; Marc G Caron; Raul R Gainetdinov
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

5.  Toward deciphering the code to aminergic G protein-coupled receptor drug design.

Authors:  Edwin S Tan; Eli S Groban; Matthew P Jacobson; Thomas S Scanlan
Journal:  Chem Biol       Date:  2008-04

Review 6.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

Review 7.  Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?

Authors:  Thomas S Scanlan
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

8.  Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.

Authors:  Maxi Cöster; Heike Biebermann; Torsten Schöneberg; Claudia Stäubert
Journal:  Eur Thyroid J       Date:  2015-05-29

9.  Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites.

Authors:  Aaron N Snead; Motonori Miyakawa; Edwin S Tan; Thomas S Scanlan
Journal:  Bioorg Med Chem Lett       Date:  2008-08-09       Impact factor: 2.823

10.  The molecular basis of species-specific ligand activation of trace amine-associated receptor 1 (TAAR(1)).

Authors:  Edwin S Tan; John C Naylor; Eli S Groban; James R Bunzow; Matthew P Jacobson; David K Grandy; Thomas S Scanlan
Journal:  ACS Chem Biol       Date:  2009-03-20       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.